Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-25-012273
Filing Date
2025-02-12
Accepted
2025-02-12 17:17:04
Documents
1
Period of Report
2025-02-10

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm256127d2_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm256127d2_4seq1.xml 4 9308
  Complete submission text file 0001104659-25-012273.txt   11107
Mailing Address 825 INDUSTRIAL ROAD 4TH FLOOR SAN CARLOS CA 94070
Business Address 825 INDUSTRIAL ROAD 4TH FLOOR SAN CARLOS CA 94070 6502607120
IOVANCE BIOTHERAPEUTICS, INC. (Issuer) CIK: 0001425205 (see all company filings)

EIN.: 753254381 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 825 INDUSTRIAL ROAD SUITE 400 SAN CARLOS CA 94070
Business Address
Kirby Daniel Gordon (Reporting) CIK: 0002055001 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36860 | Film No.: 25616072